Research programme: viral vaccines - CPL Biologicals

Drug Profile

Research programme: viral vaccines - CPL Biologicals

Alternative Names: Recombinant nanoparticle vaccines - CPL Biologicals

Latest Information Update: 20 May 2014

Price : $50

At a glance

  • Originator CPL Biologicals
  • Class Protein-vaccines; Virus-like particle vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Preclinical Rabies
  • Research Unspecified

Most Recent Events

  • 22 Jan 2014 Rabies G protein vaccine has entered clinical development in India
  • 01 Mar 2013 CPL Biologicals plans a phase I trial for Rabies in India in 2013
  • 03 Jul 2012 Early research in Undefined indication in India (Parenteral)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top